![CIDD_linkedinheader[1]](http://research.utsa.edu/wp-content/uploads/2016/06/CIDD_linkedinheader1.jpg)
The Center for Innovative Drug Discovery (CIDD) will hold its second annual Drug Discovery Symposium on June 9-10, 2016 on the UTSA Main Campus.
“This year’s CIDD symposium will showcase presentations by researchers from national, state, and local San Antonio academic institutions and pharmaceutical companies, focusing on multiple research aspects within contemporary drug discovery research”, explained Stanton McHardy, director of the CIDD. Since its inception in 2012 as a joint venture between UTSA and UTHSCSA, the CIDD has built collaborative drug discovery programs across multiple therapeutic areas such as cancers, regenerative medicine and brain health, infectious disease and others. The ultimate intent of the CIDD is to provide a diverse array of core facilities and expertise to facilitate the translation of basic scientific discoveries into tangible pre-clinical candidate drugs that can be further developed into clinical therapies for human disease.
This year’s CIDD symposium will allow researchers and students to immerse themselves into the multi-disciplinary and collaborative research areas associated with drug discovery. Students will also have a unique opportunity to present research at poster session and interact one on one with leading researchers in the drug discovery field.
The keynote speaker is Dr. Craig Lindsley from Vanderbilt University where he is co-director and director of medicinal chemistry for the Vanderbilt Center for Neuroscience Drug Discovery (VCNDD). Dr. Lindsley is one of the premier academic researchers in the field of drug discovery and was awarded the Portoghese Lectureship from the ACS MEDI division and the Journal of Medicinal Chemistry for impact in the field of medicinal chemistry. He also received the John J. Abel Award in Pharmacology from ASPET. Dr. Lindsley holds over 60 issued US patents and has published over 400 manuscripts and another 140 published patent applications.
Academic and industry researchers will showcase ongoing research to facilitate knowledge exchange and promote scientific collaborations among institutions and industries in Texas and beyond. Invited speakers are specialists in various areas of drug discovery research from both academics and industry. Some of the speakers for the two-day event include Mike White, UT Southwestern; Gaston Habets, Plexicon Inc.; Conor Caffrey, UC San Diego.; Stan Watowich, UTMB Galveston; Stephen Martin, UT Austin; Jef K. De Brabander, UT Southwestern.; Phil Jones, MD Anderson; Graham Beaton, Curtana Inc.; Rong Li, UTHSCSA; Bob Messing, UT Austin; Thomas Knott, Cytocentrics Inc.; Luke Larison, Scripps CA; Rob Davey, Texas Biomedical Institute; Jose Lopez Ribot, UTSA and George Perry, UTSA.
The CIDD Symposium organizing committee members are: Stanton McHardy and Doug Frantz from UTSA and Matt Hart and Bruce Nicholson from UTHSCSA.
